TETRASODIUM 2-((4-CHLORO-6-((3-(2-(1-(2,5-DICHLORO-4-SULFONATOPHENYL)-3-METHYL-5-OXO-4H-PYRAZOL-4-YL)DIAZEN-1-YL)-4-SULFONATOPHENYL)AMINO)-1,3,5-TRIAZIN-2-YL)AMINO)-5-SULFONATOBENZOATE
UNII 5NR2M7B6OJ
Substance Identification & Data
This profile provides standardized clinical and technical data for Tetrasodium 2-((4-chloro-6-((3-(2-(1-(2,5-dichloro-4-sulfonatophenyl)-3-methyl-5-oxo-4h-pyrazol-4-yl)diazen-1-yl)-4-sulfonatophenyl)amino)-1,3,5-triazin-2-yl)amino)-5-sulfonatobenzoate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 5NR2M7B6OJ.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 89923-42-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C26H14Cl3N9O12S3.4Na AKFKVOMNPMURJS-UEVOHEPMSA-J Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for Tetrasodium 2-((4-chloro-6-((3-(2-(1-(2,5-dichloro-4-sulfonatophenyl)-3-methyl-5-oxo-4h-pyrazol-4-yl)diazen-1-yl)-4-sulfonatophenyl)amino)-1,3,5-triazin-2-yl)amino)-5-sulfonatobenzoate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.